The new study, presented at the American Academy of Pain Medicine’s annual meeting, shows that patients’ response to intraarticular sacroiliac steroid injections was not an accurate predictor of their subsequent responses to radiofrequency ablation treatment.
Patients with less than 50 perfect pain relief following the injections should not be disqualified from receiving radiofrequency ablation treatment, the study concluded.
Related Articles on Pain Management:
Long Term Opioid Use Can Lead to Hormonal Abnormalities, Study Says
Chronic Pain Can be Measured With Bar Code, Researchers Say
Low Dose of Naltexone Reduces Pain in Fibromyalia Patients, Study Finds
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
